Real-time enrollment status for this peripheral t cell lymphoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 12:55 AM UTC
| NCT Number | NCT03922724 |
| Recruiting Status | Recruiting |
| Condition | Peripheral T Cell Lymphoma |
| Phase | PHASE2 |
| Target Enrollment | 330 participants |
| Active Locations | 2 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | July 17, 2026 (Yesterday) |
As of July 18, 2026: Clinical trial NCT03922724 is currently recruiting participants. This phase2 study for peripheral t cell lymphoma is actively seeking new participants at 2 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03922724 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03922724 was last updated Yesterday (July 17, 2026). HelloStudys verifies this status automatically.